Ozempic (semaglutide) is an injection prescribed for certain uses in adults with type 2 diabetes. It’s not known whether Ozempic may be safe to receive while pregnant or breastfeeding.
It’s not known whether Ozempic is safe to receive during pregnancy. Your doctor may only have you receive Ozempic during pregnancy if the possible benefits of treatment outweigh the risks.
If you plan to become pregnant, Ozempic’s manufacturer recommends stopping Ozempic treatment at least 2 months before you become pregnant. This waiting period ensures your body fully clears the drug from your system.
Type 2 diabetes and pregnancy
Type 2 diabetes that’s difficult to manage during pregnancy can increase the risk of certain negative effects. These include:
- preeclampsia
- diabetes-related ketoacidosis
- premature (early) birth
- delivery complications
- early stage pregnancy loss
- stillbirth
- problems with fetal development (commonly known as birth defects)
Because of this, you and your doctor should discuss the risks and benefits of receiving Ozempic while pregnant versus not treating your condition during pregnancy or receiving another drug.
It’s not known whether it’s safe to receive Ozempic while breastfeeding or whether Ozempic passes into human breast milk. In animal studies, experts found small amounts of Ozempic in breast milk, but it’s unclear whether this applies to humans.
If you’re currently breastfeeding or planning to do so, talk with your doctor before starting Ozempic treatment.
Disclaimer: Healthline has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.